FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085652129> ?p ?o ?g. }

• W2085652129 endingPage "75" @default.
• W2085652129 startingPage "67" @default.
• W2085652129 abstract "To evaluate the prognostic factors and impact on survival of neoadjuvant oral and infusional chemoradiotherapy in patients with locally advanced rectal cancer. There is still no definitive consensus about the prognostic factors and the impact of neoadjuvant chemoradiotherapy on survival. Some studies have pointed to an improvement in overall survival (OS) and progression-free survival (PFS) in patients with tumor downstaging (TD) and nodal downstaging (ND). A set of 159 patients with LARC were treated preoperatively. Group A – 112 patients underwent concomitant oral chemoradiotherapy: capecitabine or UFT + folinic acid. Group B – 47 patients submitted to concomitant chemoradiation with 5-FU in continuous infusion. 63.6% of patients were submitted to adjuvant chemotherapy. Group A: pathologic complete response (pCR) – 18.7%; TD – 55.1%; ND – 76%; loco-regional response – 74.8%. Group B: pCR – 11.4%; TD – 50%; ND – 55.8%; LRR – 54.5%. The loco-regional control was 95.6%. There was no difference in survival between both groups. Those with loco-regional response had better PFS. Tumor and nodal downstaging, loco-regional response and a normal CEA level turned out to be important prognostic factors in locally advanced rectal cancer. Nodal downstaging and loco-regional response were higher in Group A. Those with tumor downstaging and loco-regional response from Group A had better OS. Adjuvant chemotherapy had no impact on survival except in those patients with loco-regional response who achieved a higher PFS." @default.
• W2085652129 created "2016-06-24" @default.
• W2085652129 creator A5004548901 @default.
• W2085652129 creator A5013393080 @default.
• W2085652129 creator A5047726921 @default.
• W2085652129 creator A5054808134 @default.
• W2085652129 creator A5071011641 @default.
• W2085652129 creator A5076372058 @default.
• W2085652129 date "2013-03-01" @default.
• W2085652129 modified "2023-09-26" @default.
• W2085652129 title "Neoadjuvant oral vs. infusional chemoradiotherapy on locally advanced rectal cancer: Prognostic factors" @default.
• W2085652129 cites W129238531 @default.
• W2085652129 cites W1896630734 @default.
• W2085652129 cites W1973487148 @default.
• W2085652129 cites W1988071481 @default.
• W2085652129 cites W1992139037 @default.
• W2085652129 cites W1992968014 @default.
• W2085652129 cites W2015633319 @default.
• W2085652129 cites W2023623711 @default.
• W2085652129 cites W2024035701 @default.
• W2085652129 cites W2027441417 @default.
• W2085652129 cites W2040660199 @default.
• W2085652129 cites W2045804591 @default.
• W2085652129 cites W2057348314 @default.
• W2085652129 cites W2065194874 @default.
• W2085652129 cites W2076889532 @default.
• W2085652129 cites W2083352053 @default.
• W2085652129 cites W2088532421 @default.
• W2085652129 cites W2098883646 @default.
• W2085652129 cites W2109740395 @default.
• W2085652129 cites W2113353705 @default.
• W2085652129 cites W2115322358 @default.
• W2085652129 cites W2117777958 @default.
• W2085652129 cites W2124107794 @default.
• W2085652129 cites W2125452425 @default.
• W2085652129 cites W2134024251 @default.
• W2085652129 cites W2134230895 @default.
• W2085652129 cites W2143655828 @default.
• W2085652129 cites W2144717403 @default.
• W2085652129 cites W2146340574 @default.
• W2085652129 cites W2160655529 @default.
• W2085652129 cites W2164574127 @default.
• W2085652129 cites W2165147735 @default.
• W2085652129 cites W2167972978 @default.
• W2085652129 cites W2188742179 @default.
• W2085652129 cites W2323577539 @default.
• W2085652129 cites W2396646859 @default.
• W2085652129 cites W2409904756 @default.
• W2085652129 cites W2415756586 @default.
• W2085652129 cites W2598363796 @default.
• W2085652129 doi "https://doi.org/10.1016/j.rpor.2012.07.010" @default.
• W2085652129 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3863241" @default.
• W2085652129 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24416533" @default.
• W2085652129 hasPublicationYear "2013" @default.
• W2085652129 type Work @default.
• W2085652129 sameAs 2085652129 @default.
• W2085652129 citedByCount "3" @default.
• W2085652129 countsByYear W20856521292014 @default.
• W2085652129 countsByYear W20856521292017 @default.
• W2085652129 crossrefType "journal-article" @default.
• W2085652129 hasAuthorship W2085652129A5004548901 @default.
• W2085652129 hasAuthorship W2085652129A5013393080 @default.
• W2085652129 hasAuthorship W2085652129A5047726921 @default.
• W2085652129 hasAuthorship W2085652129A5054808134 @default.
• W2085652129 hasAuthorship W2085652129A5071011641 @default.
• W2085652129 hasAuthorship W2085652129A5076372058 @default.
• W2085652129 hasBestOaLocation W20856521291 @default.
• W2085652129 hasConcept C121608353 @default.
• W2085652129 hasConcept C126322002 @default.
• W2085652129 hasConcept C141071460 @default.
• W2085652129 hasConcept C143998085 @default.
• W2085652129 hasConcept C2776694085 @default.
• W2085652129 hasConcept C2777863537 @default.
• W2085652129 hasConcept C2777909004 @default.
• W2085652129 hasConcept C2778292576 @default.
• W2085652129 hasConcept C2778424827 @default.
• W2085652129 hasConcept C2779384505 @default.
• W2085652129 hasConcept C2779804826 @default.
• W2085652129 hasConcept C2780456651 @default.
• W2085652129 hasConcept C526805850 @default.
• W2085652129 hasConcept C530470458 @default.
• W2085652129 hasConcept C71924100 @default.
• W2085652129 hasConceptScore W2085652129C121608353 @default.
• W2085652129 hasConceptScore W2085652129C126322002 @default.
• W2085652129 hasConceptScore W2085652129C141071460 @default.
• W2085652129 hasConceptScore W2085652129C143998085 @default.
• W2085652129 hasConceptScore W2085652129C2776694085 @default.
• W2085652129 hasConceptScore W2085652129C2777863537 @default.
• W2085652129 hasConceptScore W2085652129C2777909004 @default.
• W2085652129 hasConceptScore W2085652129C2778292576 @default.
• W2085652129 hasConceptScore W2085652129C2778424827 @default.
• W2085652129 hasConceptScore W2085652129C2779384505 @default.
• W2085652129 hasConceptScore W2085652129C2779804826 @default.
• W2085652129 hasConceptScore W2085652129C2780456651 @default.
• W2085652129 hasConceptScore W2085652129C526805850 @default.
• W2085652129 hasConceptScore W2085652129C530470458 @default.
• W2085652129 hasConceptScore W2085652129C71924100 @default.
• W2085652129 hasIssue "2" @default.

• next